Dr. Oliver Mutschlechner

Chief Executive Officer (CEO), Founder

PhD and MSc in Biochemistry / Biotechnology (Technical University of Vienna, Austria)

25 years of professional experience in development of biologics in research, pharma and biotech (Companies: Octapharma, Intercell, Apeiron)

Positions in R&D, QC/QA, qualified person, regulatory affairs, manufacturing and executive management

Strong focus on projects and company goals in the field of vaccine development, oncology/immuno-oncology and hematology

Strong background in generating value by successful transition from early development to global commercialization